+140.3%
IVZ vs THC
+238.5%
-98.2%
-36.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.1% | +0.6% | +0.5% | +1.0% |
| 7D | +0.6% | -0.7% | +1.3% | +0.8% |
| 30D | +4.0% | +1.3% | +2.7% | +3.7% |
| 3M | +18.2% | +64.2% | -46.1% | +5.3% |
| 6M | +32.8% | +8.3% | +24.6% | +29.8% |
| YTD | +28.7% | +33.4% | -4.6% | +19.1% |
| 1Y | +55.4% | +37.7% | +17.7% | +41.7% |
| All | +140.3% | +238.5% | -98.2% | +47.3% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling